Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10059
Title: Bench-to-bedside review: Amelioration of acute renal impairment using ethyl pyruvate.
Authors: Reade, Michael C;Fink, Mitchell P
Affiliation: Austin Hospital/University of Melbourne, Heidelberg, Melbourne, Victoria, Australia. mreade@doctors.net.uk
Issue Date: 21-Oct-2005
Citation: Critical Care (london, England) 2005; 9(6): 556-60
Abstract: Inflammation and oxidative stress cause renal impairment. Renal failure exacerbates the effect of oxidative stress on many organ systems. Antioxidants can prevent or treat renal failure in various experimental models and clinical situations. Pyruvate is an endogenous antioxidant with beneficial effects in animal models of oxidative stress. Because sodium pyruvate rapidly degrades in solution, a simple derivative of pyruvic acid, namely ethyl pyruvate, has been investigated as a therapeutic agent in preclinical studies. Ethyl pyruvate reduces organ system damage in ischaemia/reperfusion injury and haemorrhagic and endotoxic shock, at least in part through its antioxidant action. In addition, ethyl pyruvate appears to have direct beneficial effects on cytokine expression and proinflammatory gene regulation. The effect is long lasting and, importantly, even when it is administered after the onset of inflammation it can ameliorate organ damage and improve survival. Ethyl pyruvate is a widely used as a food additive and was shown to be safe in phase I clinical trials. We suggest ethyl pyruvate warrants further evaluation in the management of acute renal impairment.
Internal ID Number: 16356237
URI: http://ahro.austin.org.au/austinjspui/handle/1/10059
DOI: 10.1186/cc3892
URL: http://www.ncbi.nlm.nih.gov/pubmed/16356237
Type: Journal Article
Subjects: Acute Kidney Injury.drug therapy.etiology
Animals
Anti-Inflammatory Agents.therapeutic use
Antioxidants.therapeutic use
Drug Administration Schedule
Humans
Inflammation.complications.drug therapy
Oxidative Stress.drug effects
Pyruvates.therapeutic use
Treatment Outcome
Appears in Collections:Journal articles

Files in This Item:
File Description SizeFormat 
16356237.pdf55.83 kBAdobe PDFThumbnail
View/Open


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.